Published in Clin Exp Immunol on February 01, 2005
Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol (2006) 1.64
Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responses. J Immunol (2008) 1.11
Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease. Clin Exp Immunol (2012) 0.97
Involvement of innate immunity in the pathogenesis of intestinal Behçet's disease. Clin Exp Immunol (2008) 0.97
Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease. Clin Med Res (2006) 0.94
Pathogenesis of Behçet's disease: autoinflammatory features and beyond. Semin Immunopathol (2015) 0.88
S-antigen specific T helper type 1 response is present in Behcet's disease. Mol Vis (2008) 0.82
Aberrant Activation of Heat Shock Protein 60/65 Reactive T Cells in Patients with Behcet's Disease. Autoimmune Dis (2012) 0.80
Skewed Helper T-Cell Responses to IL-12 Family Cytokines Produced by Antigen-Presenting Cells and the Genetic Background in Behcet's Disease. Genet Res Int (2013) 0.80
Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease. Clin Rheumatol (2015) 0.77
Immunopathogenic Role of Herpes Simplex Virus in Behçet's Disease. Genet Res Int (2013) 0.76
High incidence of morphological myelodysplasia and apoptotic bone marrow cells in Behçet's disease. J Clin Immunol (2007) 0.75
T helper 1-related molecules as well as IL-15 are hyperexpressed in the skin lesions of patients with pyoderma gangrenosum. Clin Exp Immunol (2017) 0.75
Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet (1990) 19.57
Behçet's disease. N Engl J Med (1999) 7.74
Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol (2001) 6.30
Signaling and transcription in T helper development. Annu Rev Immunol (2000) 3.44
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51. Ann Rheum Dis (2001) 1.94
Cytokine profile in Behçet's disease patients. Relationship with disease activity. Scand J Rheumatol (2002) 1.74
Association between the 65-kilodalton heat shock protein, Streptococcus sanguis, and the corresponding antibodies in Behçet's syndrome. Infect Immun (1991) 1.45
Behçet syndrome. Curr Opin Rheumatol (2004) 1.41
T cell epitope expression of mycobacterial and homologous human 65-kilodalton heat shock protein peptides in short term cell lines from patients with Behçet's disease. J Immunol (1993) 1.37
Behçet's disease: from Hippocrates to the third millennium. Br J Ophthalmol (2003) 1.30
Divergent cytokine production profile in Behçet's disease. Altered Th1/Th2 cell cytokine pattern. J Rheumatol (1998) 1.29
Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Bechçet's disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol (1997) 1.29
Th1 polarization of the immune response in Behçet's disease: a putative pathogenetic role of interleukin-12. Arthritis Rheum (1999) 1.27
Macrophages induce cellular immunity by activating Th1 cell responses and suppressing Th2 cell responses. J Immunol (1998) 1.27
Immunohistology of skin pathergy reaction in Behçet's disease. Br J Dermatol (1995) 1.19
Characterization of T cells specific for an epitope of human 60-kD heat shock protein (hsp) in patients with Behcet's disease (BD) in Japan. Clin Exp Immunol (1997) 1.18
T-bet expression is upregulated in active Behçet's disease. Br J Ophthalmol (2003) 1.18
Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease. Invest Ophthalmol Vis Sci (1998) 1.17
Abnormal T cell responses to bacterial superantigens in Behçet's disease (BD). Clin Exp Immunol (1998) 1.14
T cell responses to 60/65 kDa heat shock protein derived peptides in Turkish patients with Behçet's disease. J Rheumatol (2000) 1.09
Immunology and functional genomics of Behçet's disease. Cell Mol Life Sci (2003) 1.07
Natural killer cell activity, interferon-gamma and antibodies to herpes viruses in patients with Behçet's disease. Clin Exp Immunol (1990) 1.05
Txk, a nonreceptor tyrosine kinase of the Tec family, is expressed in T helper type 1 cells and regulates interferon gamma production in human T lymphocytes. J Exp Med (1999) 1.03
Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease. Arch Dermatol Res (1996) 1.02
Identification of Rlk, a novel protein tyrosine kinase with predominant expression in the T cell lineage. J Biol Chem (1995) 1.01
Behçet's disease: activated T lymphocytes in retinal perivasculitis. Br J Ophthalmol (1992) 1.01
Txk, a member of nonreceptor tyrosine kinase of Tec family, acts as a Th1 cell-specific transcription factor and regulates IFN-gamma gene transcription. J Immunol (2002) 1.01
Experimental mucosal induction of uveitis with the 60-kDa heat shock protein-derived peptide 336-351. Eur J Immunol (1998) 0.95
Pathogenesis of Adamantiades-Behçet's disease. Med Microbiol Immunol (2003) 0.92
TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. Hum Immunol (2003) 0.90
Differential expression of mRNA for Th1 and Th2 cytokine-associated transcription factors and suppressors of cytokine signalling in peripheral blood mononuclear cells of patients with atopic dermatitis. Clin Exp Immunol (2004) 0.89
Characterization of Streptococcus sanguis isolated from patients with Behçet's disease. Microbiol Immunol (1995) 0.88
IL-18 mRNA expression and IFN-gamma induction in bronchoalveolar lavage from Behçet's disease. Clin Exp Rheumatol (2004) 0.88
Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. Tissue Antigens (2001) 0.84
Molecular mechanisms in Behçet's disease. Br J Ophthalmol (2003) 0.84
Heat shock proteins, HLA-DR and rheumatoid arthritis. Nat Med (1998) 0.84
In vivo mechanisms for the inhibition of T lymphocyte activation by long-term therapy with tacrolimus (FK-506): experience in patients with Behçet's disease. Arthritis Rheum (1997) 0.83
Linkage mapping of a novel susceptibility locus for Behçet's disease to chromosome 6p22-23. Arthritis Rheum (2001) 0.82
Aberrant Fas ligand expression in lymphocytes in patients with Behçet's disease. Int Arch Allergy Immunol (2002) 0.79
The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature (1997) 33.47
Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01
Behçet's disease. N Engl J Med (1999) 7.74
Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology (2007) 6.61
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron (1994) 6.41
New type of POU domain in germ line-specific protein Oct-4. Nature (1990) 5.65
Structure and function of the region of the replication origin of the Bacillus subtilis chromosome. III. Nucleotide sequence of some 10,000 base pairs in the origin region. Nucleic Acids Res (1985) 4.56
Regulation of DNA-replication origins during cell-cycle progression. Nature (1998) 4.52
A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor. EMBO J (1989) 4.47
Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology (2004) 4.24
The chromosome of Bacillus subtilis. I. Theory of marker frequency analysis. Genetics (1965) 3.75
Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody. Dev Biol (1984) 3.56
Expansive open-door laminoplasty for cervical spinal stenotic myelopathy. Spine (Phila Pa 1976) (1983) 3.53
Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev (1999) 3.41
Amyloid beta protein (A beta) deposition: A beta 42(43) precedes A beta 40 in Down syndrome. Ann Neurol (1995) 3.34
Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity (2000) 3.29
Nucleotide sequence of the major early region of bacteriophage phi 29. Gene (1982) 3.26
Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43). J Biol Chem (1995) 3.17
Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis. J Neurol Neurosurg Psychiatry (2007) 3.12
DNA synthesis during germination of Bacillus subtilis spores. Proc Natl Acad Sci U S A (1965) 3.09
The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25. Oncogene (2001) 2.97
The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci U S A (1999) 2.87
GM1 ganglioside-bound amyloid beta-protein (A beta): a possible form of preamyloid in Alzheimer's disease. Nat Med (1995) 2.77
Systematic sequencing of the 180 kilobase region of the Bacillus subtilis chromosome containing the replication origin. DNA Res (1994) 2.70
Octamer binding proteins confer transcriptional activity in early mouse embryogenesis. EMBO J (1989) 2.70
Unbinding force of a single motor molecule of muscle measured using optical tweezers. Nature (1995) 2.64
Cloning and nucleotide sequence of phoP, the regulatory gene for alkaline phosphatase and phosphodiesterase in Bacillus subtilis. J Bacteriol (1987) 2.52
Structure and organization of rRNA operons in the region of the replication origin of the Bacillus subtilis chromosome. Nucleic Acids Res (1983) 2.40
Genes and their organization in the replication origin region of the bacterial chromosome. Mol Microbiol (1992) 2.39
The efficiency and timing of initiation of replication of multiple replicons of Saccharomyces cerevisiae chromosome VI. Genes Cells (1997) 2.38
Cloning of monomeric human papillomavirus type 16 DNA integrated within cell DNA from a cervical carcinoma. J Virol (1986) 2.28
Nucleotide sequence of a cloned woodchuck hepatitis virus genome: evolutional relationship between hepadnaviruses. J Virol (1985) 2.24
Increased plasma level of endothelin-1 and coronary spasm induction in patients with vasospastic angina pectoris. Circulation (1991) 2.23
Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques (1990) 2.22
Retracted A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J (2001) 2.21
A detailed linkage map of medaka, Oryzias latipes: comparative genomics and genome evolution. Genetics (2000) 2.19
Mutagenesis of the N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4, 5-b]pyridine DNA adduct in mammalian cells. Sequence context effects. J Biol Chem (1999) 2.17
Stepwise motion of an actin filament over a small number of heavy meromyosin molecules is revealed in an in vitro motility assay. J Biochem (1994) 2.11
Incidence of portal vein thrombosis in liver cirrhosis. An angiographic study in 708 patients. Gastroenterology (1985) 2.11
Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident. Cancer Res (1999) 2.07
Boundary cells between longitudinal and circular layers: essential for electrical slow waves in cat intestine. Am J Physiol (1986) 2.05
In vivo analysis of the promoter structure of the influenza virus RNA genome using a transfection system with an engineered RNA. Proc Natl Acad Sci U S A (1991) 2.03
Comparison of the effect of 18-month daily teriparatide administration on patients with rheumatoid arthritis and postmenopausal osteoporosis patients. Osteoporos Int (2014) 2.03
Nucleotide sequence of the Bacillus subtilis phoR gene. J Bacteriol (1988) 2.02
Studies on erythrocyte glycolysis. I. Determination of the glycolytic intermediates in human erythrocytes. J Biochem (1965) 1.97
Conservation of genes and their organization in the chromosomal replication origin region of Bacillus subtilis and Escherichia coli. EMBO J (1985) 1.96
MRI of cervical intervertebral discs in asymptomatic subjects. J Bone Joint Surg Br (1998) 1.92
Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer. Gut (2007) 1.90
The effect of spo0 mutations on the expression of spo0A- and spo0F-lacZ fusions. Mol Gen Genet (1986) 1.89
Preservation of the bone mineral density of the femur after surface replacement of the hip. J Bone Joint Surg Br (2004) 1.88
Location and characterization of autonomously replicating sequences from chromosome VI of Saccharomyces cerevisiae. Mol Cell Biol (1993) 1.88
Epstein-Barr virus (EBV)-specific cytotoxic T lymphocytes for the treatment of patients with EBV-positive relapsed Hodgkin's disease. Blood (1998) 1.86
Lymphoid chemokine B cell-attracting chemokine-1 (CXCL13) is expressed in germinal center of ectopic lymphoid follicles within the synovium of chronic arthritis patients. J Immunol (2001) 1.85
Human parvovirus B19 infection associated with acute hepatitis. Lancet (1996) 1.82
Asymmetric bidirectional replication of Bacillus subtilis chromosome. Nat New Biol (1973) 1.81
Increased plasma concentrations of endothelin-1 and big endothelin-1 in acute myocardial infarction. Lancet (1989) 1.80
Nucleotide sequences at the termini of phi 29 DNA. Proc Natl Acad Sci U S A (1981) 1.76
Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol (2000) 1.76
Identification of a suppressor sequence for DNA replication in the replication origin region of the Bacillus subtilis chromosome. Proc Natl Acad Sci U S A (1982) 1.75
Structure of the dnaA region of Pseudomonas putida: conservation among three bacteria, Bacillus subtilis, Escherichia coli and P. putida. Mol Gen Genet (1989) 1.72
Increase in nucleoli after x-radiation of fibroblasts of patients with Gorlin syndrome. J Lab Clin Med (1999) 1.72
Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J Exp Med (1998) 1.70
Ablation of cerebellar Golgi cells disrupts synaptic integration involving GABA inhibition and NMDA receptor activation in motor coordination. Cell (1998) 1.69
Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J Virol (1999) 1.66
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol (1993) 1.66
Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (1997) 1.65
Behcet's disease. Clin Exp Med (2004) 1.65
Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol (2006) 1.64
Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am J Gastroenterol (1998) 1.64
Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell line. Eur J Cancer Clin Oncol (1989) 1.64
Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration (2004) 1.63
Inflammatory pseudotumor of the liver: case report and review of the literature. J Pediatr Surg (2001) 1.61
Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer. Br J Cancer (2007) 1.60
Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1. Clin Immunol (2001) 1.59
Levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea--hypopnea syndrome. Blood (2001) 1.58
Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung. Int J Cancer (1998) 1.57
Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation (2001) 1.56
Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides. Biochem Pharmacol (2000) 1.56
In vitro construction of pseudovirions of human papillomavirus type 16: incorporation of plasmid DNA into reassembled L1/L2 capsids. J Virol (1998) 1.55
Structure of the dnaA region of Micrococcus luteus: conservation and variations among eubacteria. Gene (1990) 1.55
Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford) (2008) 1.53
Acute pulmonary edema after intravenous liquid halothane in dogs. Anesth Analg (1992) 1.53
Variation in the photochemical reactivity of thymine in the DNA of B. subtilis spores, vegetative cells and spores germinated in chloramphenicol. Photochem Photobiol (1966) 1.52
Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102). Br J Cancer (2013) 1.50
Effect of intravenous omega-6 and omega-3 fat emulsions on nitrogen retention and protein kinetics in burned rats. Nutrition (1999) 1.50
Volumetric coronary angiography using the 256-detector row computed tomography scanner: comparison in vivo and in vitro with porcine models. Acta Radiol (2006) 1.50
Immunity to Toxoplasma gondii induced in vitro in non-immune mouse macrophages with specifically immune lymphocytes. J Immunol (1975) 1.50
Topography of chromosome membrane junction in Bacillus subtilis. Nat New Biol (1973) 1.50
Expression of cyclooxygenase-2 in prostate carcinoma. Cancer (2000) 1.49
The relationship between disturbed transit and dilated bowel, and manometric findings of dilated bowel in patients with duodenal atresia and stenosis. J Pediatr Surg (1997) 1.49
Defective bacteriophage PBSH in Bacillus subtilis. II. Intracellular development of the induced prophage. J Virol (1969) 1.49
The initiation of DNA replication in Bacillus subtilis. Proc Natl Acad Sci U S A (1967) 1.48
Defects of cholecystokinin (CCK)-A receptor gene expression and CCK-A receptor-mediated biological functions in Otsuka Long-Evans Tokushima Fatty (OLETF) rats. J Gastroenterol (1998) 1.47
Intraoperative extracorporeal autogenous irradiated bone grafts in tumor surgery. Clin Orthop Relat Res (1999) 1.47